13F HOLDINGS REPORT
Sands Capital Ventures, LLC
Quarter ended Q4 2023 · Filed November 14, 2023 · Accession 0001846444-23-000004
Total Value
$338.0M
Positions
23
Other Managers
0
Confidential Omitted
No
Holdings (23)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | NU HLDGS LTD | NU | 9,152,548 | $66.4M | 19.63% |
| 2 | UIPATH INC | PATH | 3,066,569 | $52.5M | 15.52% |
| 3 | DOORDASH INC | DASH | 603,512 | $48.0M | 14.19% |
| 4 | SNOWFLAKE INC | SNOW | 215,799 | $33.0M | 9.75% |
| 5 | RAYZEBIO, INC. | 75525N107 | 1,195,589 | $26.5M | 7.85% |
| 6 | SAMSARA INC | IOT | 934,737 | $23.6M | 6.97% |
| 7 | 10X GENOMICS INC | TXG | 481,770 | $19.9M | 5.88% |
| 8 | KLAVIYO, INC. | KVYO | 469,431 | $16.2M | 4.79% |
| 9 | ACRIVON THERAPEUTICS INC | ACRV | 1,652,605 | $15.8M | 4.67% |
| 10 | ACUMEN PHARMACEUTICALS INC | ABOS | 3,417,075 | $14.2M | 4.20% |
| 11 | OLINK HLDG AB | OLN | 705,514 | $10.4M | 3.08% |
| 12 | TARSUS PHARMACEUTICALS INC | TARS | 260,000 | $4.6M | 1.37% |
| 13 | TAYSHA GENE THERAPIES INC | TSHA | 724,873 | $2.3M | 0.68% |
| 14 | SPRUCE BIOSCIENCES INC | SPRB | 787,007 | $1.8M | 0.53% |
| 15 | 908 DEVICES INC | MASS | 237,258 | $1.6M | 0.47% |
| 16 | CANDEL THERAPEUTICS INC | CADL | 811,737 | $746,798 | 0.22% |
| 17 | CROWDSTRIKE HLDGS INC | CRWD | 865 | $144,784 | 0.04% |
| 18 | COUPANG INC | CPNG | 8,438 | $143,446 | 0.04% |
| 19 | TOAST INC | TOST | 7,121 | $133,376 | 0.04% |
| 20 | DATADOG INC | DDOG | 1,366 | $124,429 | 0.04% |
| 21 | ABSCI CORPORATION | ABSI | 57,804 | $76,301 | 0.02% |
| 22 | CONFLUENT INC | 20717M103 | 1,161 | $34,377 | 0.01% |
| 23 | GITLAB INC | GTLB | 658 | $29,755 | 0.01% |